Healthcare Frost Radar™: Neuromodulation Devices, 2026

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

INDUSTRY
Healthcare

RELEASE DATE
24-Jul-2026
REGION
Global
DELIVERABLE TYPE
Frost Radar

RESEARCH CODE
KCCE-01-00-00-00
SKU
HC_2026_34759
Yes
SHARE

Frost Radar™: Neuromodulation Devices, 2026
Published on: 24-Jul-2026 | SKU: HC_2026_34759

Need more details?
$4,950.00
DownloadLink
Need more details?

Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life, gaining momentum as a cost-efficient, long-term treatment for neurological and nerve-related disorders. The prevalence of neurological disorders and nerve injuries, an aging population, and increasing government support and funding for neurological research are sustaining long-term investment in neuromodulation technology. Chronic pain remains the largest application segment, with spinal cord stimulators continuing to hold the largest device-type share, though psychiatric and mental health applications are emerging as the fastest-growing new frontier. Ecosystem partners including rehabilitation centers, digital health platforms, and neurology centers of excellence are extending the commercial reach of device manufacturers beyond traditional hospital settings. Expanding regulatory and reimbursement pathways are lowering adoption barriers. In January 2026, the US Food and Drug Administration (FDA) cleared the first prescription, at-home neuromodulation therapy for depression, signaling regulatory comfort with non-invasive, home-based devices.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Author: Bejoy Daniel

Abbott

BIOTRONIK

Boston Scientific

CEFALY Technology

electroCore

Inspire Medical Systems

LivaNova

Medtronic

Neuronetics

NeuroPace

Nevro

Nyxoah

Saluda Medical

Theranica

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO's Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Medical Devices research

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

04 Aug 2026   |   Global   |   Market Research

Global Capnography Devices Market, Forecast to 2031

The capnography market is undergoing a significant transformation from its traditional role in anesthesia and intensive care monitoring to a broader, continuous respiratory surveillance ecosystem. This evolution is being driven by increasing integration of capnography into multiparameter monitoring ...

30 Jul 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Wearables and Drug Delivery Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.The issue features advanced medical devices such as non-invasive bimodal neurom...

07 Jul 2026   |   Global   |   Technology Research

Emerging Technology Trends in Surgical Robotics

The research study analyzes how emerging surgical robotics technologies are evolving in response to pressing unmet needs across hospitals and ambulatory surgical centers (ASCs) such as high cost of ownership, operating room (OR) efficiency bottlenecks, reprocessing workload, and interoperability gap...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life, gaining momentum as a cost-efficient, long-term treatment for neurological and nerve-related disorders. The prevalence of neurological disorders and nerve injuries, an aging population, and increasing government support and funding for neurological research are sustaining long-term investment in neuromodulation technology. Chronic pain remains the largest application segment, with spinal cord stimulators continuing to hold the largest device-type share, though psychiatric and mental health applications are emerging as the fastest-growing new frontier. Ecosystem partners including rehabilitation centers, digital health platforms, and neurology centers of excellence are extending the commercial reach of device manufacturers beyond traditional hospital settings. Expanding regulatory and reimbursement pathways are lowering adoption barriers. In January 2026, the US Food and Drug Administration (FDA) cleared the first prescription, at-home neuromodulation therapy for depression, signaling regulatory comfort with non-invasive, home-based devices.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Author: Bejoy Daniel
More Information
Deliverable Type Frost Radar
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Neuromodulation Devices Market Report
Keyword 2 Neuromodulation Market Analysis
Keyword 3 Neurostimulation Devices Report
Podcast No
Predecessor None
WIP Number KCCE-01-00-00-00

Frost Radar™: Neuromodulation Devices, 2026

$4,950.00
In stock
SKU
HC_2026_34759